-
CREST Results: Carotid Endarterectomy vs Stenting
-
Pediatric Stroke: Causes and Management
-
Psychotropic Therapy in Suicidal Adolescents: Effective in Reducing Readmission?
-
CDC Commentary: Duchenne Muscular Dystrophy -- Considerations for Care
-
AAPM 2009 Expert Video: A Primary Care Perspective
-
AAPM 2009 Expert Video: Multimodal Therapy in Pain
-
TPA 3.0-4.5 Hours After Acute Stroke: A Subgroup Analysis
-
The Role of Mild Induced Hypothermia in Cardiac Arrest
-
Naproxcinod -- Does This New Drug Mean That Safe Pain Relief Is at Hand?
-
Medical Complications After Stroke
-
Antiplatelet and Anticoagulant Drug Management Before Surgery: New Guidance and Implications
-
Reducing Salt -- The Next Public Health Frontier. Benefits Are Dramatic and the Harm Is Minimal.
AAPM 2010: Top Research Slideshow
Diseases of the Nails: Slideshow
Antipsychotics in Children and the Elderly: Controversies, Issues, and Ethics: Slideshow
Leprosy: Slideshow
Radiological Society of North America (RSNA) 2009 Annual Meeting: Slideshow
Pain Management: Slideshow
Creutzfeldt-Jakob Disease: Slideshow
Acute Stroke: Slideshow
Neurocysticercosis: Slideshow 
Recognizing Child Abuse: Slideshow
Carpal Tunnel Syndrome: Slideshow
Ticks and Tick-Borne diseases: Slideshow
Community Blogs
Commentary and Interviews
POLL
A recent study in The Lancet shows that cognitive behavioral therapy (CBT) may significantly improve subacute and chronic low back pain. An editorialist points out that CBT may not be cost-effective and compliance could be low. How likely are you to prescribe CBT for your patients with low back pain?
Advisory Board
Site Editorial Director
- ABILIFY® (aripiprazole)
- Clinical Management Center
- NUCYNTA™ (tapentadol)
- NUVIGIL® (armodafinil) Tablets [C-IV]
- OPANA® ER (oxymorphone HCl)
- PLAVIX® (clopidogrel bisulfate) Explore this extensive on-line informational resource
- REBIF® (interferon beta-1a)
- STALEVO® (carbidopa, levodopa and entacapone) tablets
Also of Interest
- Coffee Associated With Lower Risk of Arrhythmias
- Physicians Say Onerous "Meaningful Use" Requirements Could Make EHR Incentives Meaningless
Guidelines in the News
Genomics and Neurology
- A Genetic Panel With That Dilantin Level, Please?
- Clinical Features of Spinal and Bulbar Muscular Atrophy
